Marqeta Chief Product Officer Eugenia Gibbons received 585,721 derivative securities across two transactions dated September 15 at $0 per share. The disclosure gives investors a precise record of the award size, transaction pricing and her resulting holding of 87,858 derivative securities.
Key Highlights
- The transactions were dated September 15, 2026.
- Both entries used SEC transaction code A, identifying awards or grants.
- Eugenia Gibbons held 87,858 derivative securities after the transactions.
Marqeta, Inc. (NASDAQ: MQ) awarded 585,721 derivative securities to Chief Product Officer Eugenia Gibbons across two transactions. The awards were recorded at $0 per share.
September 15 Award Transactions Both
transactions were dated September 15, 2026, and each used SEC transaction code A, in insider transaction classifications, code A denotes an award or grant. The company identified Eugenia Gibbons as its Chief Product Officer in the transaction record. The securities awarded were derivative securities, with the per-share value set at $0. After the two transactions, Gibbons held 87,858 derivative securities.
FAQs
Q: What did Marqeta award Eugenia Gibbons?
A: Marqeta awarded Eugenia Gibbons 585,721 derivative securities across two transactions. The filing reports two transactions and lists a $0 per-share value for the awards.
Q: Were Marqeta’s insider transactions purchases or awards?
A: Both transactions used code A, which identifies an award or grant. The filing dates both entries to September 15, 2026.
Q: How many derivative securities did Eugenia Gibbons hold afterward?
A: Eugenia Gibbons held 87,858 derivative securities after the two Marqeta transactions. The filing states this amount as her post-transaction holding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.